LGM
Logos Global Management Portfolio holdings
AUM
$749M
This Quarter Return
+8.76%
1 Year Return
+18.94%
3 Year Return
+431.72%
5 Year Return
+481.1%
10 Year Return
–
AUM
$701M
AUM Growth
+$701M
(-3.2%)
Cap. Flow
-$35.3M
Cap. Flow
% of AUM
-5.03%
Top 10 Holdings %
Top 10 Hldgs %
53.83%
Holding
68
New
17
Increased
15
Reduced
11
Closed
15
Top Buys
| 1 |
Rocket Pharmaceuticals
RCKT
|
$35.3M |
| 2 |
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
$15.3M |
| 3 |
Roivant Sciences
ROIV
|
$14M |
| 4 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$13.5M |
| 5 |
IDEAYA Biosciences
IDYA
|
$13.5M |
Top Sells
| 1 |
Spyre Therapeutics
SYRE
|
$35.9M |
| 2 |
Biogen
BIIB
|
$28.5M |
| 3 |
Immunovant
IMVT
|
$25M |
| 4 |
Neurocrine Biosciences
NBIX
|
$16.9M |
| 5 |
Arcellx
ACLX
|
$15.8M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
KalVista Pharmaceuticals
KALV
$732M
| $8.67M | 1.16% |
+900,000
| New | +$8.67M |
|
27
Ventyx Biosciences
VTYX
$183M
| $7.81M | 1.04% |
225,000
-25,000
| -10% | -$868K |
|
28
Crinetics Pharmaceuticals
CRNX
$3.25B
| $7.44M | 0.99% |
+250,000
| New | +$7.44M |
|
|
GRCL
29
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $7.27M | 0.97% |
2,525,000
+725,000
| +40% | +$2.09M |
|
|
CMPS
30
Compass Pathways
CMPS
$449M
| $7.03M | 0.94% |
+950,000
| New | +$7.03M |
|
31
Revolution Medicines
RVMD
$7.52B
| $6.92M | 0.92% |
+250,000
| New | +$6.92M |
|
|
MOR
32
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $6.38M | 0.85% |
950,000
-250,000
| -21% | -$1.68M |
|
33
Geron
GERN
$912M
| $5.83M | 0.78% |
2,750,000
+550,000
| +25% | +$1.17M |
|
34
Merus
MRUS
$5.05B
| $5.78M | 0.77% |
+245,000
| New | +$5.78M |
|
35
ALX Oncology
ALXO
$55.7M
| $4.8M | 0.64% |
1,000,000
| – | – |
|
36
89bio
ETNB
$1.38B
| $4.79M | 0.64% |
+310,000
| New | +$4.79M |
|
37
Delcath Systems
DCTH
$385M
| $4.23M | 0.56% |
1,044,444
-134,343
| -11% | -$544K |
|
38
Enliven Therapeutics
ELVN
$1.24B
| $4.19M | 0.56% |
307,076
| – | – |
|
39
Astria Therapeutics
ATXS
$388M
| $4.07M | 0.54% |
544,960
| – | – |
|
40
Soleno Therapeutics
SLNO
$3.57B
| $3.69M | 0.49% |
+125,000
| New | +$3.69M |
|
41
Repare Therapeutics
RPTX
$73.9M
| $3.62M | 0.48% |
+300,000
| New | +$3.62M |
|
|
VERV
42
DELISTED
Verve Therapeutics
VERV
| $2.85M | 0.38% |
+215,000
| New | +$2.85M |
|
43
Zura Bio
ZURA
$133M
| $2.8M | 0.37% |
+424,000
| New | +$2.8M |
|
|
44
Spyre Therapeutics
SYRE
$1.04B
| $2.57M | 0.34% |
210,000
-2,932,880
| -93% | -$35.9M |
|
|
AMAM
45
DELISTED
Ambrx Biopharma, Inc. Common Stock
AMAM
| $1.32M | 0.18% |
+115,000
| New | +$1.32M |
|
|
VIGL
46
DELISTED
Vigil Neuroscience
VIGL
| $1.02M | 0.14% |
188,390
| – | – |
|
47
IO Biotech
IOBT
$115M
| $696K | 0.09% |
+493,827
| New | +$696K |
|
48
Immunic
IMUX
$79.4M
| $619K | 0.08% |
421,184
| – | – |
|
49
Leap Therapeutics
LPTX
$12.2M
| $489K | 0.07% |
+354,266
| New | +$489K |
|
50
Tyra Biosciences
TYRA
$680M
| $439K | 0.06% |
31,872
| – | – |
|